---
title: "KISELAK TOMAS — Ownership Dossier"
canonical: https://whiteintel.dev/entity/9960f70d-a149-596d-9d75-7007a5604f13
json: https://whiteintel.dev/api/public/dossier/9960f70d-a149-596d-9d75-7007a5604f13
identifier: sec:0001830177
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# KISELAK TOMAS

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001830177`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/9960f70d-a149-596d-9d75-7007a5604f13  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/9960f70d-a149-596d-9d75-7007a5604f13  

## Ownership & control

### Holdings / subsidiaries

- **CRESCENT BIOPHARMA, INC.** (director) — https://whiteintel.dev/entity/af95539c-09bd-5667-a03e-8cd2e3451859
- **AEROVATE THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/0498d804-2189-5885-b4d8-f0171a454d64
- **Oruka Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/7e85ba7b-eb29-5fad-98be-13d2eb920dce
- **Spyre Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/bf7dce76-8d4f-5fee-ba09-97415a847c12
- **CRESCENT BIOPHARMA, INC.** (tenpercentowner) — https://whiteintel.dev/entity/af95539c-09bd-5667-a03e-8cd2e3451859
- **Zenas BioPharma, Inc.** (director) — https://whiteintel.dev/entity/8a62e26a-40ca-50e6-b06d-efea9f8a52da
- **AEROVATE THERAPEUTICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/0498d804-2189-5885-b4d8-f0171a454d64
- **Oruka Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/7e85ba7b-eb29-5fad-98be-13d2eb920dce
- **Apogee Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/940e2d6d-e01a-5392-8151-5669c20cff67
- **Galecto, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/ec4e19eb-a5b7-5678-b5ed-541e820a9625
- **Viridian Therapeutics, Inc.\DE** (director) — https://whiteintel.dev/entity/15a737c3-567b-5102-941a-d6bdd1d83278
- **Dianthus Therapeutics, Inc. /DE/** (director) — https://whiteintel.dev/entity/6a3adac7-6100-5ac2-87d8-2e2620ec6a23

…and **3** more subsidiaries/holdings. Resolve the full list with `get_dossier` on the WhiteIntel MCP (`npx -y @whiteintel/mcp-server`) or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **KISELAK TOMAS** — https://whiteintel.dev/entity/9960f70d-a149-596d-9d75-7007a5604f13 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **KISELAK TOMAS**. Human view: https://whiteintel.dev/entity/9960f70d-a149-596d-9d75-7007a5604f13 · Structured JSON: https://whiteintel.dev/api/public/dossier/9960f70d-a149-596d-9d75-7007a5604f13._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._